Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
UCB 9608 is an inhibitor of PI4KIIIβ (IC50 = 11 nM). It is selective for PI4KIIIβ over 8 other phosphatidylinositol kinases at 10 µM.1 UCB 9608 inhibits the mixed lymphocyte reaction in isolated human peripheral blood mononuclear cells (PBMCs; IC50 = 37 nM). It increases heart allograft survival in mice when administered at a dose of 5 mg/kg per day.
WARNING This product is not for human or veterinary use.
1. Discovery of a potent, orally bioavailable PI4KIIIβ inhibitor (UCB9608) able to significantly prolong allogeneic organ engraftment in vivo. J. Med. Chem. 61(15), 6705-6723 (2018).